Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

TATDN3 Activators

The chemical class known as TATDN3 activators encompasses a range of compounds that can trigger the engagement of TATDN3, a protein with a DNAse domain that suggests its involvement in DNA digestion processes. These activators do not directly bind to or modify the TATDN3 protein; instead, their activation mechanism is rooted in the induction of cellular stress, particularly that of DNA damage. When DNA is damaged, a cascade of cellular repair mechanisms is initiated, necessitating the function of various DNA repair proteins, which can include TATDN3. The activation of TATDN3 by these chemicals occurs as a result of the cell's response to maintain genomic integrity. This response includes a complex network of signaling pathways that detect DNA damage, halt the cell cycle to prevent the propagation of errors, and recruit the appropriate repair machinery.

Within this dynamic cellular environment, TATDN3 activators can instigate the DNA damage response (DDR) by introducing single or double-strand breaks, intercalating into DNA strands, or creating DNA crosslinks. These disruptions to the DNA structure prompt the cell to deploy its repair toolkit. The DNA repair process is a carefully orchestrated event involving multiple proteins and enzymes, and the activation of TATDN3 can be an integral part of this response. As the cell works to rectify the damage, TATDN3 can be summoned to manage the DNA lesions, ensuring that the genetic material is restored to its original state. This class of chemicals, by challenging the fidelity of the genome, indirectly necessitates the heightened presence and activity of DNA repair proteins, including TATDN3, to reinstate genomic stability.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

Camptothecin interferes with DNA replication and can induce DNA damage, possibly activating DNA repair mechanisms where TATDN3 could be involved.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Etoposide causes DNA strand breaks and could enhance the DNA damage response, possibly upregulating DNA repair proteins including TATDN3.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$78.00
$260.00
18
(1)

Hydroxyurea inhibits ribonucleotide reductase, leading to replication stress and could increase reliance on DNA repair pathways that involve TATDN3.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$138.00
$380.00
101
(4)

Cisplatin forms DNA crosslinks that require repair, potentially engaging TATDN3's activity in the DNA damage response.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$66.00
$101.00
$143.00
85
(5)

Mitomycin C crosslinks DNA, which can trigger a cellular response that might involve TATDN3 as part of the DNA repair machinery.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$176.00
$426.00
43
(3)

Doxorubicin intercalates DNA and induces breaks, possibly activating pathways that require TATDN3 for DNA repair.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Methotrexate inhibits dihydrofolate reductase, affecting DNA synthesis and repair, which could influence the function of TATDN3.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$210.00
$305.00
$495.00
10
(1)

Olaparib is a PARP inhibitor that interferes with DNA repair; it could lead to increased activity of other DNA repair enzymes, possibly including TATDN3.